News
Stories from the news about advancements made in the digital health industry, within our portfolio companies, and at OTV.
Stories from the news about advancements made in the digital health industry, within our portfolio companies, and at OTV.
Donisi Health was selected as the winner of the 2021 Med in Israel competition
ViaSurgical's CEO, Lena Levin, discusses 'conscience laws' and their impact on health tech
Campfire emerged from Stealth today to introduce its new eponymous AR and VR headset, which features a 92 degree field of view.
Via Surgical raises funds from Catcher Technology, making its first investment in the medical device field — Via Surgical was selected after a thorough scouting process supported by the Ministry of Economy and Industry Economic Mission in Taipei.
Study shows “Open-System Colon Irrigation Bowel Prep for Colonoscopy is a Safe and Effective Alternative to Oral Prep “
Watch the interview to learn about HyGieaCare.
Lamor Corporation is pleased to announce the acquisition of the licensing rights to HARBO Technologies' product line.
The Israeli startup raised the first $50 million in April 2020 in a round led by Insight Partners, which led this extension as well.
Clinicians can now monitor patient blood oxygen levels with the new Pulse Oximeter. This adapter connects directly to a patient's TytoHome exam kit, and once placed on their finger, can monitor and track clinical-level results in real-time.
The world's first "completely automated genetic interpretation platform" has recently announced its partnership with biotech giant Illumina to power its genomic data interpretation and scale up genetic data analysis and possibly, discovery.
The new additions bring the total number of approved projects to more than 1,020 over 43 years
A non-exclusive partnership between Illlumina and AI-based precision medicine company Emedgene will seek to automate the interpretation of rare genetic disease data into the TruSight software suite of products from Illumina.
OTV (formerly known as Olive Tree Ventures), an Israeli venture capital firm that focuses on digital health tech, announced it has closed a new fund totaling $170 million.
OTV, formerly Olive Tree Ventures, closed its first fund of $170 million dedicated to digital health investments.
In a world that is producing more and more data, how can geneticists interpret that data and extract actionable insights so they can act fast and produce the best medical care?
HyGIeaCare Inc. presented data showing that inner-colonic bacteria and microbiome are unique and profoundly different than than those of stool samples.
The First Ever Solution to Enable Digitization and Analysis of Full Field Peripheral Blood Smears with Decision Support System (DSS) Tailored to Augment Hematology Diagnostics.
The third quarter of 2020 ended with more than $6.6B in health innovation funding, making it the most-funded quarter this market has ever seen since we began tracking funding in 2010.
Clinicians can now monitor patient blood oxygen levels with the new Pulse Oximeter. This adapter connects directly to a patient's TytoHome exam kit, and once placed on their finger, can monitor and track clinical-level results in real-time.
Medasense Biometrics Ltd. announced today that its NOL® pain response monitoring device (PMD-200™) has been approved for marketing in Brazil by ANVISA, the Brazilian health regulatory agency.
The company's technology uses a multi-parametric sensor platform and advanced AI algorithms to convert complicated data into a patient's "Signature of Pain."
Israel is in a second lockdown due to Covid-19 until at least mid-October, but that has not stopped its medical technology industry — indeed the pandemic has boosted demand for some of its products.
Emedgene has added automatic classification of copy-number variants to its genomic interpretation platform, following 2020 American College of Medical Genomics (ACMG) and Clinical Genome Resource (ClinGen) guidelines.
The aim of this study was to determine simple risk factors for severe pain intensity, to analyse their relation to other patient-reported outcome measures and to develop a simple prediction model
As the COVID-19 pandemic continues to rage, telemedicine is becoming the latest luxury residential must-have
Tyto Care, creator of the global healthcare industry’s first all-in-one modular device and telehealth platform for on-demand, remote medical exams, and SWICA, one of Switzerland’s leading health insurance companies, announced their partnership.
2020 midyear digital health market update by Rock Health
During the coronavirus pandemic, telemedicine looks like the future of health care. Is it a future we want?
Telehealth has helped expand access to care at a time when the pandemic has severely restricted patients’ ability to see their doctors. Actions taken by healthcare leaders today will determine if the full potential of telehealth will be realized.
Interest in telemedicine continues to increase, and Lemonaid Health raised an oversubscribed $33 million Series B round of funding to develop its on-demand platform for accessing health care online.
Collaboration Offers Eastern VetPath Clients Immediate Access to Its Pathology Experts
The First Ever Solution to Enable Digitization and Analysis of Full Field Peripheral Blood Smears with Decision Support System (DSS) Tailored to Augment Hematology Diagnostics
Scopio Labs, an advanced digital microscopy company and SYNLAB UK & Ireland's Veterinary Pathology Group (VPG), today announced that they have signed an exclusive distribution partnership agreement.
Auto giant leads funding for smart window manufacturer together with Blue Red partners VC and Avery Dennison.
The first quarter of 2020 posted a record-breaking $4.5B in health innovation funding before the markets began their pandemic-induced decline.
TytoCare announces that it has raised $50 million in a round of funding led by Olive Tree Ventures with participation from Insight Partners and Qualcomm Ventures.
Scopio Labs, a Tel Aviv, Israel-based advanced digital microscopy company, completed a $16m Series B funding round. The round was led by Olive Tree Ventures with participation from Aurum Ventures, OurCrowd, LR group and others.
Federal Communications Commission Chairman Ajit Pai rolled out plans for a $200 million fund to help healthcare providers purchase telehealth tools to handle Covid-19.
Medasense was awarded a development grant from the Israel Innovation Authority in partnership with Dorot Rehabilitation and Geriatric Medical Center, to extend the application of NOL® pain response monitoring for noncommunicating dementia patients.
Switchable Glass with liquid crystal nanotechnology, also known as smart glass or LCG® (light control glass), allows glass windows or glass partitions to switch from transparent to privacy mode with a button, application, or remote control.
This facility is dedicated to the production of Research Frontiers’ patented SPD-Smart light control film for the entire SPD-SmartGlass industry.
Recent evidence points to promising efficacy for monitoring modalities. More investigation is required to demonstrate differences in outcome compared with traditional care, and they need to be of sufficient import to achieve widespread adoption.
The Research Report on Digital Microscopes market is a proficient and detailed analysis of the current situation of digital microscopes industry. Scopio Labs is listed as one of the key players.
HARBO Technologies was named Most Promising Energy and Clean Technology Company at the 17th Annual Energy & Clean Technology Venture Forum in Houston.
Many recent technological innovations have resulted in lesser surgical complications. Minimally invasive surgery is widely hailed as a groundbreaking healthcare milestone. Yet, there are many more challenges which need to be mitigated in due course.
At the "Auto-Shiyori" Challenge, ContinUse Biometrics announced its collaboration with Sompo Digital Lab Tel Aviv.
"We welcome Olive Tree Ventures to Hygieacare. Their investment and partnership will greatly support our commercialization efforts to significantly accelerate the expansion of Hygieacare’s footprint.” - Gavriel D. Meron, chairman & CEO of HyGIeaCare
Via Surgical announced U.S. FDA clearance of the FasTouch™ Absorbable Fixation System. The FasTouch™ enables for the first time an automated lockable surgical mesh fixation that is strong and stable yet easily and consistently delivered.
Emedgene, a company that offers clinical genetic interpretation and diagnostics, today announced a $6 million funding round to scale genomics-based care with artificial intelligence (AI).
Colorectal cancer is on the rise. The American Cancer Society recommends that people at average risk of colorectal cancer start screening at age 45 in order to find precancerous polyps so that they can be removed before they turn into cancer.
ContinUse Biometrics has announced that it has raised $20 million in a Series B financing round. The Tel Aviv based company, which is using groundbreaking research to revolutionize sensing solutions, has raised $27 million to date.
The Tel Aviv based startup has been selected by Mercedes-Benz (Daimler) to participate in the Autobahn Plug and Play accelerator.
According to the Global Genes org., eight out of ten rare diseases are caused by a faulty gene, yet it takes an average of 4.8 years to arrive at an accurate diagnosis. 30% of children with a rare disease won't live to see their fifth birthday.
In the final quarter of 2019, MobiHealthNews tracked 55 digital health funding deals totaling just over $1.7 billion. The three-month period was headlined by Bright Health’s $635 million Series D round and a $200 million raise from iFit...
How the big four US insurers rank on digital feature awareness - and what it means for customer satisfaction
Technology is improving the accuracy and efficacy of treatment, but bureaucratic precedence often wins.
The biggest tech giants—Alphabet, Amazon, Apple, and Microsoft—all focused on their healthcare plays in 2019. Apple doubled down on its big consumer- and enterprise-facing health projects and seems to have a handful of small initiatives in the works.
Ninety-five (95) percent of rare diseases do not have an approved FDA treatment that increases the gravity of the situation. Moreover, medical companies also do not pay much attention to these rare diseases.
What sectors will be disruptive and actionable in the coming year? Experts share predictions and name Israeli firms advancing these fields.
Scopio Labs advances digital cytology through launch of automated, high-resolution imaging and decision-support solutions for veterinary market
Inspiring and touching story of one persistent mother and her journey to a rare disease diagnosis at Greenwood Genetic Center with Emedgene AI (via Metro)
The third quarter of 2020 ended with more than $6.6B in health innovation funding, making it the most-funded quarter this market has ever seen since we began tracking funding in 2010.
As the COVID-19 pandemic continues to rage, telemedicine is becoming the latest luxury residential must-have
2020 midyear digital health market update by Rock Health
During the coronavirus pandemic, telemedicine looks like the future of health care. Is it a future we want?
Telehealth has helped expand access to care at a time when the pandemic has severely restricted patients’ ability to see their doctors. Actions taken by healthcare leaders today will determine if the full potential of telehealth will be realized.
The first quarter of 2020 posted a record-breaking $4.5B in health innovation funding before the markets began their pandemic-induced decline.
Federal Communications Commission Chairman Ajit Pai rolled out plans for a $200 million fund to help healthcare providers purchase telehealth tools to handle Covid-19.
Recent evidence points to promising efficacy for monitoring modalities. More investigation is required to demonstrate differences in outcome compared with traditional care, and they need to be of sufficient import to achieve widespread adoption.
In the final quarter of 2019, MobiHealthNews tracked 55 digital health funding deals totaling just over $1.7 billion. The three-month period was headlined by Bright Health’s $635 million Series D round and a $200 million raise from iFit...
How the big four US insurers rank on digital feature awareness - and what it means for customer satisfaction
Technology is improving the accuracy and efficacy of treatment, but bureaucratic precedence often wins.
The biggest tech giants—Alphabet, Amazon, Apple, and Microsoft—all focused on their healthcare plays in 2019. Apple doubled down on its big consumer- and enterprise-facing health projects and seems to have a handful of small initiatives in the works.
What sectors will be disruptive and actionable in the coming year? Experts share predictions and name Israeli firms advancing these fields.
The world's first "completely automated genetic interpretation platform" has recently announced its partnership with biotech giant Illumina to power its genomic data interpretation and scale up genetic data analysis and possibly, discovery.
A non-exclusive partnership between Illlumina and AI-based precision medicine company Emedgene will seek to automate the interpretation of rare genetic disease data into the TruSight software suite of products from Illumina.
In a world that is producing more and more data, how can geneticists interpret that data and extract actionable insights so they can act fast and produce the best medical care?
Lamor Corporation is pleased to announce the acquisition of the licensing rights to HARBO Technologies' product line.
The First Ever Solution to Enable Digitization and Analysis of Full Field Peripheral Blood Smears with Decision Support System (DSS) Tailored to Augment Hematology Diagnostics
Collaboration Offers Eastern VetPath Clients Immediate Access to Its Pathology Experts
Scopio Labs, an advanced digital microscopy company and SYNLAB UK & Ireland's Veterinary Pathology Group (VPG), today announced that they have signed an exclusive distribution partnership agreement.
Medasense Biometrics Ltd. announced today that its NOL® pain response monitoring device (PMD-200™) has been approved for marketing in Brazil by ANVISA, the Brazilian health regulatory agency.
Clinicians can now monitor patient blood oxygen levels with the new Pulse Oximeter. This adapter connects directly to a patient's TytoHome exam kit, and once placed on their finger, can monitor and track clinical-level results in real-time.
Clinicians can now monitor patient blood oxygen levels with the new Pulse Oximeter. This adapter connects directly to a patient's TytoHome exam kit, and once placed on their finger, can monitor and track clinical-level results in real-time.
Watch the interview to learn about HyGieaCare.
Study shows “Open-System Colon Irrigation Bowel Prep for Colonoscopy is a Safe and Effective Alternative to Oral Prep “
The aim of this study was to determine simple risk factors for severe pain intensity, to analyse their relation to other patient-reported outcome measures and to develop a simple prediction model
The First Ever Solution to Enable Digitization and Analysis of Full Field Peripheral Blood Smears with Decision Support System (DSS) Tailored to Augment Hematology Diagnostics.
HyGIeaCare Inc. presented data showing that inner-colonic bacteria and microbiome are unique and profoundly different than than those of stool samples.
Tyto Care, creator of the global healthcare industry’s first all-in-one modular device and telehealth platform for on-demand, remote medical exams, and SWICA, one of Switzerland’s leading health insurance companies, announced their partnership.
Emedgene has added automatic classification of copy-number variants to its genomic interpretation platform, following 2020 American College of Medical Genomics (ACMG) and Clinical Genome Resource (ClinGen) guidelines.
Inspiring and touching story of one persistent mother and her journey to a rare disease diagnosis at Greenwood Genetic Center with Emedgene AI (via Metro)
Scopio Labs advances digital cytology through launch of automated, high-resolution imaging and decision-support solutions for veterinary market
Colorectal cancer is on the rise. The American Cancer Society recommends that people at average risk of colorectal cancer start screening at age 45 in order to find precancerous polyps so that they can be removed before they turn into cancer.
According to the Global Genes org., eight out of ten rare diseases are caused by a faulty gene, yet it takes an average of 4.8 years to arrive at an accurate diagnosis. 30% of children with a rare disease won't live to see their fifth birthday.
Ninety-five (95) percent of rare diseases do not have an approved FDA treatment that increases the gravity of the situation. Moreover, medical companies also do not pay much attention to these rare diseases.
At the "Auto-Shiyori" Challenge, ContinUse Biometrics announced its collaboration with Sompo Digital Lab Tel Aviv.
Medasense was awarded a development grant from the Israel Innovation Authority in partnership with Dorot Rehabilitation and Geriatric Medical Center, to extend the application of NOL® pain response monitoring for noncommunicating dementia patients.
Many recent technological innovations have resulted in lesser surgical complications. Minimally invasive surgery is widely hailed as a groundbreaking healthcare milestone. Yet, there are many more challenges which need to be mitigated in due course.
Via Surgical announced U.S. FDA clearance of the FasTouch™ Absorbable Fixation System. The FasTouch™ enables for the first time an automated lockable surgical mesh fixation that is strong and stable yet easily and consistently delivered.
HARBO Technologies was named Most Promising Energy and Clean Technology Company at the 17th Annual Energy & Clean Technology Venture Forum in Houston.
Switchable Glass with liquid crystal nanotechnology, also known as smart glass or LCG® (light control glass), allows glass windows or glass partitions to switch from transparent to privacy mode with a button, application, or remote control.
This facility is dedicated to the production of Research Frontiers’ patented SPD-Smart light control film for the entire SPD-SmartGlass industry.
The Research Report on Digital Microscopes market is a proficient and detailed analysis of the current situation of digital microscopes industry. Scopio Labs is listed as one of the key players.